Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 196Unknown 102Recruiting 92Terminated 68Not yet recruiting 54Active not recruiting 30Withdrawn 26Enrolling by invitation 5Suspended 2Available 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Lymphoid 1Gynecologic 1Endocrine 1

Conditions

Breast Neoplasms 32Neoplasms 28Colorectal Neoplasms 19Prostatic Neoplasms 16Lung Neoplasms 13Leukemia, Myeloid, Acute 12Glioblastoma 12Stomach Neoplasms 10Head and Neck Neoplasms 10Carcinoma, Non-Small-Cell Lung 10Pancreatic Neoplasms 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Melanoma 8Glioma 8Brain Neoplasms 8Rectal Neoplasms 7Carcinoma, Hepatocellular 7Ovarian Neoplasms 6Neoplasm Metastasis 6Hematologic Neoplasms 6Uterine Cervical Neoplasms 5Polycystic Ovary Syndrome 5Myelodysplastic Syndromes 5Multiple Myeloma 5Esophageal Neoplasms 5Carcinoma, Renal Cell 5Triple Negative Breast Neoplasms 4Lymphoma, B-Cell 4Lymphoma 4Depression 4

Interventions

durvalumab 1Radiosurgery 1Platinum 1Etoposide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × OTHER × Small Cell Lung Carcinoma × Clear all
NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

M.D. Anderson Cancer Center

Phase 2 Suspended
140 enrolled
EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

University of Maryland, Baltimore

Phase 1 Suspended
50 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡